The underlying hypothesis of this proposal is that the impaired wound healing that occurs in patients with cachexia results from the profound effects of excessive tumor necrosis factor alpha (TNFa) on extracellular matrix proteins. TNFa is known to inhibit fibrillar collagen expression and to stimulate interstitial collagenase (MMP-1) expression. TNFa is a potent activator of the stress activated protein kinase (SAPK/JNK), an activator of c-JUN that in turn is the principal transcription factor stimulating the collagenase gene.
The aims of this proposal are: 1) To determine which TNFa receptor is responsible for the upregulation of collagenase and the downregulation of collagen. 2) To determine the role of ceramide in the stimulation of SAPK/JNK by TNFa. 3) To determine the intermediate steps by which TNFa activates SAPK/JNK. 4) To determine the signal transduction pathway by which TNFa inhibits type I collagen gene expression. 5) To assess potential inhibitors of TNFa signal transduction. Most of the experiments will use cultures of normal human fibroblasts, but selected experiments will involve use of mouse fibroblasts for the purpose of establishing stable transfectants. HL-60 cells will be used to examine the role of ceramide in regulating the extracellular matrix.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM041804-12
Application #
2900711
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1989-04-01
Project End
2000-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
12
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Tripathi, Anupriya; Debelius, Justine; Brenner, David A et al. (2018) The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol 15:397-411
Vollmann, Elisabeth H; Cao, Lizhi; Amatucci, Aldo et al. (2017) Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing. Mol Ther Nucleic Acids 7:314-323
Koyama, Yukinori; Wang, Ping; Liang, Shuang et al. (2017) Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis. J Clin Invest 127:1254-1270
Kim, In Hee; Kisseleva, Tatiana; Brenner, David A (2015) Aging and liver disease. Curr Opin Gastroenterol 31:184-91
Lan, Tian; Kisseleva, Tatiana; Brenner, David A (2015) Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation. PLoS One 10:e0129743
Brenner, David A; Paik, Yong-Han; Schnabl, Bernd (2015) Role of Gut Microbiota in Liver Disease. J Clin Gastroenterol 49 Suppl 1:S25-7
Paik, Yong-Han; Kim, Jonghwa; Aoyama, Tomonori et al. (2014) Role of NADPH oxidases in liver fibrosis. Antioxid Redox Signal 20:2854-72
Liu, Cheng; Chen, Xiaorong; Yang, Ling et al. (2014) Transcriptional repression of the transforming growth factor ? (TGF-?) Pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by Nuclear Factor ?B (NF-?B) p50 enhances TGF-? signaling in hepatic stellate cells. J Biol Chem 289:7082-91
Iwaisako, Keiko; Jiang, Chunyan; Zhang, Mingjun et al. (2014) Origin of myofibroblasts in the fibrotic liver in mice. Proc Natl Acad Sci U S A 111:E3297-305
Madsen, Daniel H; Leonard, Daniel; Masedunskas, Andrius et al. (2013) M2-like macrophages are responsible for collagen degradation through a mannose receptor-mediated pathway. J Cell Biol 202:951-66

Showing the most recent 10 out of 115 publications